nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—periodontitis	0.904	1	CbGaD
Phenylbutazone—PTGIS—endothelium—periodontitis	0.0126	0.324	CbGeAlD
Phenylbutazone—PTGS2—periosteum—periodontitis	0.00611	0.158	CbGeAlD
Phenylbutazone—PTGIS—connective tissue—periodontitis	0.00595	0.153	CbGeAlD
Phenylbutazone—PTGIS—Nicotinamide salvaging—PTGS2—periodontitis	0.00565	0.0992	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—periodontitis	0.00377	0.0661	CbGpPWpGaD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—GGT1—periodontitis	0.00346	0.0608	CbGpPWpGaD
Phenylbutazone—PTGIS—Nicotinate metabolism—PTGS2—periodontitis	0.00301	0.0528	CbGpPWpGaD
Phenylbutazone—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—periodontitis	0.00248	0.0435	CbGpPWpGaD
Phenylbutazone—PTGS1—endothelium—periodontitis	0.00236	0.0608	CbGeAlD
Phenylbutazone—SLC22A8—trigeminal ganglion—periodontitis	0.00226	0.0583	CbGeAlD
Phenylbutazone—PTGS2—endothelium—periodontitis	0.00225	0.0581	CbGeAlD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—periodontitis	0.00222	0.039	CbGpPWpGaD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—GGT1—periodontitis	0.00193	0.0338	CbGpPWpGaD
Phenylbutazone—PTGS2—mouth—periodontitis	0.00174	0.0448	CbGeAlD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—PTGS2—periodontitis	0.00161	0.0283	CbGpPWpGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—periodontitis	0.00135	0.0237	CbGpPWpGaD
Phenylbutazone—PTGS2—trigeminal ganglion—periodontitis	0.00128	0.0331	CbGeAlD
Phenylbutazone—PTGS1—connective tissue—periodontitis	0.00111	0.0287	CbGeAlD
Phenylbutazone—PTGS2—connective tissue—periodontitis	0.00107	0.0275	CbGeAlD
Phenylbutazone—PTGS1—Eicosanoid Synthesis—GGT1—periodontitis	0.00106	0.0187	CbGpPWpGaD
Phenylbutazone—PTGS1—epithelium—periodontitis	0.00106	0.0273	CbGeAlD
Phenylbutazone—PTGS2—epithelium—periodontitis	0.00101	0.0261	CbGeAlD
Phenylbutazone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—periodontitis	0.00092	0.0161	CbGpPWpGaD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—PTGS2—periodontitis	0.000896	0.0157	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CRP—periodontitis	0.000891	0.0156	CbGpPWpGaD
Phenylbutazone—PTGS2—Eicosanoid Synthesis—GGT1—periodontitis	0.000845	0.0148	CbGpPWpGaD
Phenylbutazone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—periodontitis	0.00082	0.0144	CbGpPWpGaD
Phenylbutazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—periodontitis	0.000763	0.0134	CbGpPWpGaD
Phenylbutazone—PTGIS—Biological oxidations—GGT1—periodontitis	0.000717	0.0126	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CRP—periodontitis	0.000707	0.0124	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—PPARA—periodontitis	0.000642	0.0113	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—PTGS2—periodontitis	0.000597	0.0105	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—GGT1—periodontitis	0.000592	0.0104	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—periodontitis	0.000583	0.0102	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CXCL8—periodontitis	0.000579	0.0102	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—periodontitis	0.000575	0.0101	CbGpPWpGaD
Phenylbutazone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—periodontitis	0.000542	0.00951	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—MPO—periodontitis	0.000497	0.00871	CbGpPWpGaD
Phenylbutazone—PTGS1—Eicosanoid Synthesis—PTGS2—periodontitis	0.000495	0.00869	CbGpPWpGaD
Phenylbutazone—PTGS2—Arachidonic acid metabolism—GGT1—periodontitis	0.00047	0.00824	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CXCL8—periodontitis	0.00046	0.00807	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SLC52A3—periodontitis	0.000446	0.00783	CbGpPWpGaD
Phenylbutazone—CYP3A4—Aflatoxin activation and detoxification—GGT1—periodontitis	0.000445	0.00781	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—periodontitis	0.000414	0.00727	CbGpPWpGaD
Phenylbutazone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.000413	0.00724	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—MPO—periodontitis	0.000409	0.00718	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—TNF—periodontitis	0.000403	0.00707	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—periodontitis	0.000396	0.00694	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—MPO—periodontitis	0.000394	0.00692	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—periodontitis	0.000377	0.00662	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—GGT1—periodontitis	0.000377	0.0066	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SLC52A3—periodontitis	0.000374	0.00656	CbGpPWpGaD
Phenylbutazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.000359	0.0063	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—periodontitis	0.000353	0.00618	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—IL6—periodontitis	0.000325	0.00571	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—TNF—periodontitis	0.00032	0.00561	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—FCGR2A—periodontitis	0.000316	0.00554	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—GGT1—periodontitis	0.000311	0.00546	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—LTF—periodontitis	0.000303	0.00532	CbGpPWpGaD
Phenylbutazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.000303	0.00532	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TGFB1—periodontitis	0.000302	0.00529	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—GGT1—periodontitis	0.000299	0.00524	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TNF—periodontitis	0.000282	0.00494	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—PTGS2—periodontitis	0.000275	0.00483	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.000275	0.00483	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CCR2—periodontitis	0.000274	0.0048	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ACP5—periodontitis	0.000263	0.00461	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CRP—periodontitis	0.000261	0.00458	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—IL6—periodontitis	0.000258	0.00453	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.000237	0.00416	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—periodontitis	0.000228	0.004	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—IL6—periodontitis	0.000227	0.00399	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ACP5—periodontitis	0.00022	0.00386	CbGpPWpGaD
Phenylbutazone—PTGS1—Biological oxidations—GGT1—periodontitis	0.00022	0.00386	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CCL2—periodontitis	0.000215	0.00377	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—periodontitis	0.000212	0.00372	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CRP—periodontitis	0.000207	0.00364	CbGpPWpGaD
Phenylbutazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.0002	0.00351	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000197	0.00345	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1A—periodontitis	0.000196	0.00344	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL4—periodontitis	0.00019	0.00333	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IFNG—periodontitis	0.000183	0.00321	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—PTGS2—periodontitis	0.000175	0.00307	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CCL2—periodontitis	0.000171	0.00299	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL1B—periodontitis	0.000163	0.00286	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.000158	0.00277	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TLR4—periodontitis	0.000157	0.00276	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.000152	0.00266	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—NOS2—periodontitis	0.00015	0.00262	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—periodontitis	0.000148	0.00259	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IFNG—periodontitis	0.000145	0.00254	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—PTGS2—periodontitis	0.000145	0.00254	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CCL2—periodontitis	0.000135	0.00237	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL1B—periodontitis	0.000129	0.00227	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000128	0.00225	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GGT1—periodontitis	0.000123	0.00215	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—TNF—periodontitis	0.000118	0.00207	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—GGT1—periodontitis	0.000116	0.00203	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC52A3—periodontitis	0.000115	0.00202	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IFNG—periodontitis	0.000115	0.00201	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—PPARA—periodontitis	0.000112	0.00196	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC52A3—periodontitis	0.000109	0.00191	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CXCL8—periodontitis	0.000107	0.00187	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1B—periodontitis	0.000102	0.0018	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MMP9—periodontitis	9.65e-05	0.00169	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL6—periodontitis	9.55e-05	0.00167	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—TNF—periodontitis	9.39e-05	0.00165	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NOS2—periodontitis	9.26e-05	0.00162	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC52A3—periodontitis	9.12e-05	0.0016	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PPARA—periodontitis	8.77e-05	0.00154	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—PPARA—periodontitis	8.52e-05	0.00149	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—GGT1—periodontitis	8.46e-05	0.00148	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	8.3e-05	0.00146	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TGFB1—periodontitis	7.95e-05	0.0014	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—GGT1—periodontitis	7.64e-05	0.00134	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL6—periodontitis	7.58e-05	0.00133	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FGF2—periodontitis	7.55e-05	0.00132	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TNF—periodontitis	7.43e-05	0.0013	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LTF—periodontitis	7.4e-05	0.0013	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—PPARA—periodontitis	7.11e-05	0.00125	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—periodontitis	6.81e-05	0.00119	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ACP5—periodontitis	6.77e-05	0.00119	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	6.71e-05	0.00118	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ACP5—periodontitis	6.42e-05	0.00113	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PPARA—periodontitis	6.05e-05	0.00106	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC52A3—periodontitis	6.04e-05	0.00106	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—periodontitis	5.99e-05	0.00105	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—periodontitis	5.7e-05	0.001	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	5.41e-05	0.000949	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ACP5—periodontitis	5.38e-05	0.000943	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	5.05e-05	0.000886	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TGFB1—periodontitis	4.92e-05	0.000864	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	4.81e-05	0.000843	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—periodontitis	4.45e-05	0.00078	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC52A3—periodontitis	3.98e-05	0.000699	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	3.94e-05	0.00069	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GGT1—periodontitis	3.77e-05	0.000661	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—periodontitis	3.71e-05	0.000651	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ACP5—periodontitis	3.56e-05	0.000624	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—periodontitis	3.18e-05	0.000558	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GGT1—periodontitis	2.99e-05	0.000525	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPARA—periodontitis	2.7e-05	0.000473	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ACP5—periodontitis	2.35e-05	0.000412	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NOS2—periodontitis	2.26e-05	0.000396	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPARA—periodontitis	2.14e-05	0.000375	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	2.07e-05	0.000363	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GGT1—periodontitis	1.98e-05	0.000347	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FGF2—periodontitis	1.84e-05	0.000323	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—periodontitis	1.75e-05	0.000307	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPARA—periodontitis	1.42e-05	0.000249	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GGT1—periodontitis	1.31e-05	0.000229	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TGFB1—periodontitis	1.2e-05	0.000211	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPARA—periodontitis	9.35e-06	0.000164	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—periodontitis	9.22e-06	0.000162	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—periodontitis	9.05e-06	0.000159	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—periodontitis	6.08e-06	0.000107	CbGpPWpGaD
